| FRESENIUS MEDICAL CARE | 64.72 / +0.65% |
| Date/Time | 05/07 / 17:22 |
| Chg. / Chg.(%) | 0.42 / +0.65% |
| Bid | - |
| Ask | - |
| Open | 64.82 |
| Previous Close | 64.30 |
| High | 65.08 |
| Low | 64.72 |
| Volume [EUR] | 29,162.16 |
| Volume [Units] | 450 |
| Price fixings | 6 |
| ISIN | DE0005785802 |
| Security | FME |
| Exchange | Borsa Italiana |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 64.640 |  |
|
| Xetra | 64.64 | |
566,604 |
| London Inter.. | 64.79 | |
160,122 |
| Cboe Europe .. | 64.62 | |
150,211 |
| Turquoise | 64.64 | |
66,914 |
| TradeGate | 64.700 | |
11,513 |
| Stuttgart | 64.740 | |
5,709 |
| gettex | 64.860 | |
5,681 |
| Cboe Europe .. | 64.81 | |
1,208 |
| Cboe Europe .. | 64.71 | |
731 |
| Frankfurt | 64.8200 |  |
683 |
| Borsa Italia.. | 64.72 | |
450 |
| München | 64.66 | |
50 |
| Vienna Globa.. | 64.66 | |
0 |
| Düsseldorf | 64.56 | |
0 |
| Hamburg | 64.34 | |
0 |
| Berlin | 64.72 | |
0 |
| Hannover | 64.38 |  |
0 |
| Mexico | 1,607.52 | |
3,490 |
| Nasdaq Other.. | 75.6000 | 80,078 | |
| EUREX | Options | ||
News
- Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
04/29/2021 / 06:05 - GlobeNewswire - R1 Announces Appointment of David Dill to Board of Directors
04/19/2021 / 23:00 - GlobeNewswire - VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
03/30/2021 / 07:00 - GlobeNewswire - Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus
03/08/2021 / 07:00 - GlobeNewswire - eGenesis Announces $125 Million Series C Financing
03/02/2021 / 14:00 - GlobeNewswire
Real-time